Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2023-03-28 00:00:00 ET · period of report 2023-03-27 · accession 0001770252-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-28 | 2023-03-27 | MYGN | Lambert Nicole | COO | S - Sale | $23.48 | -6,433 | 240.5K | -3% | -$151.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-27 | S | D | 6,433 | $23.48 | 240,506 | D | — | — |